Most searched codes in this range
Monthly US Google searches for the bare code (Google Ads, October 2026) show which entries coders and billers look up most; demand is one input to the index decision for each page and to which pages the hubs link first.
| Code | Description | Payment limit | Searches / month |
|---|---|---|---|
| J1939 | Inj, bumetanide, 0.5 mg | $0.493 | 2,400 |
| J0585 | Injection,onabotulinumtoxina | $6.514 | 1,900 |
| J0897 | Denosumab injection | $29.856 | 1,900 |
| J3301 | Triamcinolone acet inj nos | $0.787 | 1,900 |
| J1100 | Dexamethasone sodium phos | $0.099 | 1,600 |
| J9271 | Inj pembrolizumab | $62.253 | 1,600 |
| J1756 | Iron sucrose injection | $0.224 | 1,300 |
| J1885 | Ketorolac tromethamine inj | $0.569 | 1,300 |
| J1010 | Inj, methylpred acetate 1 mg | $0.123 | 1,000 |
| J1745 | Infliximab not biosimil 10mg | $29.856 | 1,000 |
Codes in this range
787 of the 847 codes carry a published October 2026 ASP payment limit, 60 show their OPPS rate instead; the remaining codes are priced by contractors or carry a limit of zero in the file. The table lists the 809 codes whose reference pages are indexed; the other 38 follow as a list, in code order across 6 pages; this page shows J0014 to J0801.
| Code | Descriptor | Unit | Limit | MUE | Col-2 pairs | Articles |
|---|---|---|---|---|---|---|
| J0014 | Cocaine hydrochloride nasal solution (goprelto), 1 mg | 1 MG | $1.825 | — | — | — |
| J0121 | Injection, omadacycline, 1 mg | 1 MG | $4.293 | 200 | — | — |
| J0122 | Injection, eravacycline, 1 mg | 1 MG | $1.333 | 300 | — | — |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10 MG | $45.937 | 100 | — | — |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 10 MG | $0.044 | 400 | — | — |
| J0132 | Injection, acetylcysteine, 100 mg | 100 MG | $0.499 | 12 | — | — |
| J0133 | Injection, acyclovir, 5 mg | 5 MG | $0.048 | 1200 | — | — |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 10 MG | $0.051 | 400 | — | — |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 10 MG | $0.046 | 400 | — | — |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 10 MG | $0.048 | 400 | — | — |
| J0138 | Injection, acetaminophen 10 mg and ibuprofen 3 mg | 10 MG/3MG | $0.129 | 400 | — | — |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 1 MG | $0.378 | 180 | — | yes |
| J0162 | Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg | 0.1 MG | $0.321 | 20 | — | — |
| J0163 | Injection, epinephrine in sodium chloride (endo), 0.1 mg | 0.1 MG | $0.71 | — | — | — |
| J0164 | Injection, epinephrine in sodium chloride (baxter), 0.1 mg | 0.1 MG | $0.912 | — | — | — |
| J0165 | Injection, epinephrine, not otherwise specified, 0.1 mg | 0.1 MG | $0.206 | 20 | — | — |
| J0166 | Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg | 0.1 MG | $0.83 | 20 | — | — |
| J0167 | Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg | 0.1 MG | $1.422 | 20 | — | — |
| J0168 | Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg | 0.1 MG | $2.697 | 20 | — | — |
| J0169 | Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg | 0.1 MG | $0.869 | 20 | — | — |
| J0174 | Lecanemab-irmb, for intravenous injection, 1 mg | 1 MG | $1.361 | — | — | — |
| J0175 | Injection, donanemab-azbt, 2 mg | 2 MG | $4.185 | 700 | — | — |
| J0177 | Injection, aflibercept hd, 1 mg | 1 MG | $290.902 | 16 | — | yes |
| J0178 | Injection, aflibercept, 1 mg | 1 MG | $722.251 | 4 | — | yes |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 1 MG | $360.439 | 12 | — | yes |
| J0180 | Injection, agalsidase beta, 1 mg | 1 MG | $230.54 | 140 | — | — |
| J0185 | Injection, aprepitant, 1 mg | 1 MG | $1.624 | 130 | — | — |
| J0202 | Injection, alemtuzumab, 1 mg | 1 MG | $2,506.20 | 12 | — | yes |
| J0206 | Injection, allopurinol sodium, 1 mg | 1 MG | $4.292 | 1000 | — | — |
| J0208 | Injection, sodium thiosulfate (pedmark), 100 mg | 100 MG | $101.284 OPPS | 500 | — | — |
| J0217 | Injection, velmanase alfa-tycv, 1 mg | 1 MG | $479.191 | 150 | — | — |
| J0218 | Injection, olipudase alfa-rpcp, 1 mg | 1 MG | $404.784 | 460 | — | — |
| J0219 | Injection, avalglucosidase alfa-ngpt, 4 mg | 4 MG | $83.816 | 750 | — | — |
| J0221 | Injection, alglucosidase alfa, (lumizyme), 10 mg | 10 MG | $211.056 | 250 | — | — |
| J0222 | Injection, patisiran, 0.1 mg | 0.1 MG | $101.181 | 300 | — | — |
| J0223 | Injection, givosiran, 0.5 mg | 0.5 MG | $120.744 | 756 | — | — |
| J0224 | Injection, lumasiran, 0.5 mg | 0.5 MG | $336.64 | 945 | — | — |
| J0225 | Injection, vutrisiran, 1 mg | 1 MG | $5,008.939 | 25 | — | — |
| J0248 | Injection, remdesivir, 1 mg | 1 MG | $7.511 | 200 | — | — |
| J0256 | Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg | 10 MG | $5.077 | 1600 | — | — |
| J0257 | Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg | 10 MG | $5.64 | 1400 | — | — |
| J0278 | Injection, amikacin sulfate, 100 mg | 100 MG | $0.612 | 15 | — | — |
| J0280 | Injection, aminophyllin, up to 250 mg | 250 MG | $10.757 | 7 | — | yes |
| J0281 | Injection, aminocaproic acid, 1 gram | 1 GM | $1.738 | 30 | — | — |
| J0282 | Injection, amiodarone hydrochloride, 30 mg | 30 MG | $0.384 | 35 | — | — |
| J0283 | Injection, amiodarone hydrochloride (nexterone), 30 mg | 30 MG | $2.763 | 35 | — | — |
| J0285 | Injection, amphotericin b, 50 mg | 50 MG | $42.474 | 5 | — | — |
| J0289 | Injection, amphotericin b liposome, 10 mg | 10 MG | $17.851 | 50 | — | — |
| J0290 | Injection, ampicillin sodium, 500 mg | 500 MG | $0.619 | 24 | — | — |
| J0291 | Injection, plazomicin, 5 mg | 5 MG | $3.519 | 500 | — | — |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 1.5 GM | $1.457 | 12 | — | — |
| J0348 | Injection, anidulafungin, 1 mg | 1 MG | $0.452 | 200 | — | — |
| J0349 | Injection, rezafungin, 1 mg | 1 MG | $11.182 | 400 | — | — |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 20 MG | $3.344 | 2 | — | — |
| J0391 | Injection, artesunate, 1 mg | 1 MG | $51.829 OPPS | 770 | — | — |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | 1 MG | $7.456 | 400 | — | — |
| J0402 | Injection, aripiprazole (abilify asimtufii), 1 mg | 1 MG | $6.185 | 960 | — | — |
| J0456 | Injection, azithromycin, 500 mg | 500 MG | $2.571 | 4 | — | — |
| J0457 | Injection, aztreonam, 100 mg | 100 MG | $2.299 | 80 | — | — |
| J0458 | Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg) | 10 MG | $1.756 | — | — | — |
| J0461 | Injection, atropine sulfate, 0.01 mg | 0.01 MG | $0.104 | 200 | — | yes |
| J0462 | Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg | 0.01 MG | $0.129 | — | — | — |
| J0463 | Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg | 0.01 MG | $0.02 | — | — | — |
| J0475 | Injection, baclofen, 10 mg | 10 MG | $186.996 | 8 | — | — |
| J0476 | Injection, baclofen, 50 mcg for intrathecal trial | 50 MCG | $46.539 | 2 | — | — |
| J0480 | Injection, basiliximab, 20 mg | 20 MG | $4,917.63 | 1 | — | — |
| J0485 | Injection, belatacept, 1 mg | 1 MG | $3.883 | 1500 | — | — |
| J0490 | Injection, belimumab, 10 mg | 10 MG | $58.333 | 160 | — | — |
| J0491 | Injection, anifrolumab-fnia, 1 mg | 1 MG | $18.461 | 300 | — | — |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 20 MG | $12.061 | 4 | — | — |
| J0515 | Injection, benztropine mesylate, per 1 mg | 1 MG | $12.262 | 3 | — | — |
| J0517 | Injection, benralizumab, 1 mg | 1 MG | $165.08 | 30 | — | — |
| J0528 | Injection, fosfomycin disodium, 20 mg | 20 MG | $0.633 | — | — | — |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | 100,000 UNITS | $19.523 | 24 | — | — |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 100,000 UNITS | $25.612 | 24 | — | — |
| J0567 | Injection, cerliponase alfa, 1 mg | 1 MG | $124.22 OPPS | 300 | — | — |
| J0577 | Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy | Less than or equal to 7 days of therapy | $433.167 | 1 | — | — |
| J0578 | Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy | Greater than 7 days and up to 28 days of therapy | $1,732.667 | 1 | — | — |
| J0582 | Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg | 1 MG | $0.168 | — | — | — |
| J0583 | Injection, bivalirudin, 1 mg | 1 MG | $0.165 | 250 | — | — |
| J0584 | Injection, burosumab-twza 1 mg | 1 MG | $516.85 | 90 | — | — |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1 UNIT | $6.514 | 800 | — | yes |
| J0586 | Injection, abobotulinumtoxina, 5 units | 5 Unit | $8.937 | 300 | — | yes |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | 100 UNITS | $13.301 | 300 | — | yes |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | 1 UNIT | $5.262 | 600 | — | yes |
| J0589 | Injection, daxibotulinumtoxina-lanm, 1 unit | 1 UNIT | $3.252 | 300 | — | yes |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | 0.1 MG | $4.698 | 6 | — | — |
| J0593 | Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) | 1 mg | $88.34 | 300 | — | — |
| J0594 | injection, busulfan, 1 mg | 1 MG | $0.839 | 320 | — | — |
| J0595 | Injection, butorphanol tartrate, 1 mg | 1 MG | $11.316 | 8 | — | — |
| J0596 | Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units | 10 UNITS | $37.81 | 840 | — | — |
| J0597 | Injection, c-1 esterase inhibitor (human), berinert, 10 units | 10 UNITS | $79.329 | 250 | — | — |
| J0598 | Injection, c-1 esterase inhibitor (human), cinryze, 10 units | 10 UNITS | $67.065 | 100 | — | — |
| J0600 | Injection, edetate calcium disodium, up to 1000 mg | 1000 MG | $6,273.865 | 3 | — | — |
| J0606 | Injection, etelcalcetide, 0.1 mg | 0.1 MG | $2.457 OPPS | 150 | — | — |
| J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg | 10 MG | $0.024 | 800 | — | — |
| J0613 | Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg | 10 MG | $0.041 | 800 | — | — |
| J0614 | Injection, treosulfan, 50 mg | 50 MG | $32.33 | 600 | — | — |
| J0616 | Injection, metoprolol tartrate, 1 mg | 1 MG | $0.14 | 15 | — | — |
| J0637 | Injection, caspofungin acetate, 5 mg | 5 MG | $2.463 | 20 | — | — |
| J0638 | Injection, canakinumab, 1 mg | 1 MG | $156.953 | 300 | — | — |
| J0641 | Injection, levoleucovorin, not otherwise specified, 0.5 mg | 0.5 MG | $0.053 | 1200 | — | — |
| J0642 | Injection, levoleucovorin (khapzory), 0.5 mg | 0.5 MG | $1.336 | 1200 | — | — |
| J0644 | Injection, leucovorin calcium (avyxa), 1 mg | 1 MG | $2.625 | — | — | — |
| J0650 | Injection, levothyroxine sodium, not otherwise specified, 10 mcg | 10 MCG | $6.581 | 100 | — | — |
| J0651 | Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg | 10 MCG | $7.079 | 100 | — | — |
| J0652 | Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg | 10 MCG | $6.315 | 100 | — | — |
| J0654 | Injection, liothyronine, 1 mcg | 1 MCG | $41.492 OPPS | 100 | — | — |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0.5 MG | $0.01 | — | — | — |
| J0666 | Injection, bupivacaine liposome, 1 mg | 1 MG | $1.426 | 266 | — | — |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 10 ML | $4.367 | 10 | 1548 | — |
| J0681 | Injection, ceftobiprole medocaril sodium, 3 mg | 3 MG | $1.098 | — | — | — |
| J0687 | Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg | 500 MG | $0.663 | 16 | — | — |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 500 MG | $1.281 | 16 | — | — |
| J0690 | Injection, cefazolin sodium, 500 mg | 500 MG | $0.781 | 16 | — | — |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 500 MG | $1.292 | 12 | — | — |
| J0694 | Injection, cefoxitin sodium, 1 gm | 1 GM | $5.416 | 8 | — | — |
| J0695 | Injection, ceftolozane 50 mg and tazobactam 25 mg | 75mg (50mg cft/25mg taz) | $10.015 | 60 | — | — |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 250 MG | $0.39 | 16 | — | — |
| J0697 | Injection, sterile cefuroxime sodium, per 750 mg | 750 MG | $2.106 | 4 | — | — |
| J0699 | Injection, cefiderocol, 10 mg | 10 mg | $2.564 | 600 | — | — |
| J0701 | Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg | 500 MG | $6.096 | 12 | — | — |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 3 MG & 3 MG | $7.175 | 18 | — | yes |
| J0703 | Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg | 500 MG | $4.748 | 12 | — | — |
| J0712 | Injection, ceftaroline fosamil, 10 mg | 10 MG | $4.008 | 120 | — | — |
| J0713 | Injection, ceftazidime, per 500 mg | 500 MG | $1.549 | 12 | — | — |
| J0714 | Injection, ceftazidime and avibactam, 0.5 g/0.125 g | .625 GM | $109.454 | 12 | — | — |
| J0716 | Injection, centruroides immune f(ab)2, up to 120 milligrams | UP TO 120MG | $5,449.649 | 4 | — | — |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1 MG | $3.14 | 400 | — | — |
| J0725 | Injection, chorionic gonadotropin, per 1,000 usp units | 1000 UNITS | $14.439 | 10 | — | — |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 1 MG | $14.192 | 50 | — | — |
| J0736 | Injection, clindamycin phosphate, 300 mg | 300 MG | $1.854 | 9 | — | — |
| J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg | 300 MG | $2.068 | 9 | — | — |
| J0738 | Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | 1 MG | $16.016 | — | — | — |
| J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | 1 mg | $7.278 | 600 | — | — |
| J0740 | Injection, cidofovir, 375 mg | 375 MG | $522.238 | 2 | — | — |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 2MG/3MG | $24.649 | 300 | — | — |
| J0742 | Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg | 4 MG-4 MG-2 MG | $2.696 | 500 | — | — |
| J0743 | Injection, cilastatin sodium; imipenem, per 250 mg | 250 MG | $6.796 | 16 | — | — |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 200 MG | $1.93 | 6 | — | — |
| J0750 | Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) | 200 mg/300 mg | $0.451 | — | — | — |
| J0751 | Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) | 200 mg/25 mg | $74.941 | — | — | — |
| J0752 | Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | 300 MG | $617.946 | — | — | — |
| J0759 | Injection, clevidipine butyrate, 1 mg | 1 MG | $2.95 | 300 | — | — |
| J0770 | Injection, colistimethate sodium, up to 150 mg | 150 MG | $18.051 | 5 | — | — |
| J0775 | Injection, collagenase, clostridium histolyticum, 0.01 mg | 0.01 MG | $81.072 | 180 | — | — |
| J0780 | Injection, prochlorperazine, up to 10 mg | 10 MG | $2.475 | 4 | — | — |
| J0791 | Injection, crizanlizumab-tmca, 5 mg | 5 MG | $129.949 | 160 | — | — |
| J0801 | Injection, corticotropin (acthar gel), up to 40 units | 40 UNITS | $3,884.267 | 3 | — | — |
Show the other 3 codes on this page (pages not yet in search results)
- J0643 Injection, leucovorin calcium, not otherwise specified, 1 mg · limit $0.054
- J0675 Injection, carboprost tromethamine, 0.1 mg · OPPS $17.605
- J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg · limit $0.829
How to read this table
The limit is the Medicare Part B payment allowance per billing unit for the quarter shown, not per dose: multiply it by the units that the administered quantity divided by the descriptor unit produces. Codes marked OPPS have no ASP limit and show the hospital outpatient rate per unit instead. The MUE column is the practitioner-setting Medically Unlikely Edit, the maximum units CMS expects on one date of service; facility and DME limits can differ and appear on each code page. Column-2 pairs counts the active NCCI procedure-to-procedure edits in which the code is the bundled component, and Articles marks codes that at least one Medicare Administrative Contractor lists in a current Billing and Coding Article with covered diagnosis codes. Codes without a published limit are contractor-priced or carry a zero limit in the CMS file.
In QuickIntell research
- October 2026 ASP movers report: The 75 drug codes whose payment limit moved 20% or more since July 2026, and the 37 priced for the first time.
- October 2026 HCPCS update report: The codes CMS added and discontinued in the latest quarterly release, with replacements; the 2026 roll-up covers every quarter.
- 2026 Q4 most-bundled codes report: The codes NCCI bundles most often as column 2, and the 12 Part B drug codes it bundles at all.
- J codes by drug name: Find the J code, or every code, for a drug by generic or brand name.
For teams evaluating QuickIntell software
Evaluate software for HCPCS coding workflows
Evaluating a recurring coding workflow? Review QuickCode for qualified coder review, documentation clarification and the billing handoff. Use your unit, modifier and edit questions to confirm the supported scope; a published CMS table does not establish an automated claim check.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
How many codes are in drugs administered other than oral method, chemotherapy drugs (j codes)?
847 Part B drug codes in this range: 787 carry an ASP payment limit in the October 2026 file and 60 are paid separately under OPPS without an ASP limit; 809 have enough joined CMS data (MUE, NCCI, OPPS, ASC or coverage) to be published as full reference pages.
Which payers use these payment limits?
Medicare Part B contractors apply the ASP limits directly. Medicaid programs and commercial payers publish their own fee schedules, which often reference ASP but at different percentages.
Why do some codes show no MUE?
CMS withholds some MUE values as confidential and applies them without publication; others have no unit limit. A code with no published MUE can still deny for units when the quantity is implausible for the dose.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
Disclaimer
Operational reference compiled from CMS publications. Payment limits are Medicare national amounts; other payers differ. CPT codes appear as numbers only. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.